Abstract: A computer-implemented method of locally verifying an attribute associated with a user is disclosed. The method comprises performing, by a computing device, steps including: capturing biometric verification data using the computing device; determining whether the biometric verification data corresponds to the user by comparing the biometric verification data with authenticated biometric data of the user previously obtained from an identity document, ID, and stored locally on the computing device; and in response to determining that the biometric verification data corresponds to the user, verifying the attribute associated with the user based on attribute information associated with the user previously obtained from the ID and stored locally on the computing device.

Abstract: The systems and devices described provide for a user selectable CPO interface for both duplex and parallel optical network interfaces. The systems include a pluggable optical device with a laser source subassembly, an internal optical connector, a plurality of laser source optical paths connecting the laser source subassembly to the internal optical connector, and an external optical connector. The system also includes a plurality of transmit optical paths connecting the internal optical connector and the external optical connector and a plurality of receive paths connecting the internal optical connector and the external optical connector.

Abstract: The invention provides binding agents and assays tor insulin signal peptide. The agents and assays are useful in methods tor predicting, diagnosing, assessing or monitoring acute cardiac disorders, glucose handling disorders and diabetes in a subject. Also provided are nucleotides, polypeptides, and kits useful in the methods of the invention.

Abstract: The invention provides binding agents and assays tor insulin signal peptide. The agents and assays are useful in methods tor predicting, diagnosing, assessing or monitoring acute cardiac disorders, glucose handling disorders and diabetes in a subject. Also provided are nucleotides, polypeptides, and kits useful in the methods of the invention.

Abstract: The invention provides binding agents and assays for insulin signal peptide. The agents and assays are useful in methods for predicting, diagnosing, assessing or monitoring acute cardiac disorders, glucose handling disorders and diabetes in a subject. Also provided are nucleotides, polypeptides, and kits useful in the methods of the invention.

Abstract: A method, system, and computer-readable medium for a network interface with adjustable rate are disclosed. For example, one method involves receiving a request to activate a virtual lane of an interface, where the request is received by a first node. The interface is configured to facilitate data communication between the first node and a second node, and the interface includes a plurality of virtual lanes that include at least one active virtual lane, and at least one inactive virtual lane. The method also involves, in response to receiving the request, negotiating with the second node to select an additional virtual lane from the at least one inactive virtual lane. The method involves activating the additional virtual lane. After the activating, the first node and the second node are configured to use the active virtual lane(s) and the additional virtual lane for data communication.

Abstract: The invention provides methods for predicting, diagnosing or monitoring acute cardiac disorders, cardiac transplant rejection, or distinguishing acute cardiac disorders from pulmonary disorders, by measuring BNP signal peptide levels in a sample taken from a subject shortly after onset of, or presentation with the disorder or transplant rejection.

Abstract: The invention provides methods for predicting, diagnosing or monitoring acute cardiac disorders, cardiac transplant rejection, or distinguishing acute cardiac disorders from pulmonary disorders, by measuring BNP signal peptide levels in a sample taken from a subject shortly after onset of, or presentation with the disorder or transplant rejection.

Abstract: A fixed Generic Mapping Procedure (GMP) apparatus and method are provided to map client data to an optical transport frame. Client data to be mapped into a payload field of an optical transport frame is received and store in a memory. Timing information is generated based on bit and fractional bit granularity of client data mapped into the payload field of successive optical transport frames for use in recovering the client data from received optical transport frames.

Abstract: A method, system, and computer-readable medium for a network interface with adjustable rate are disclosed. For example, one method involves receiving a request to activate a virtual lane of an interface, where the request is received by a first node. The interface is configured to facilitate data communication between the first node and a second nod, and the interface includes a plurality of virtual lanes that include at least one active virtual lane, and at least one inactive virtual lane. The method also involves, in response to receiving the request, negotiating with the second node to select an additional virtual lane from the at least one inactive virtual lane. The method involves activating the additional virtual lane. After the activating, the first node and the second node are configured to use the active virtual lane(s) and the additional virtual lane for data communication.

Abstract: The invention provides methods for predicting, diagnosing or monitoring acute cardiac disorders, cardiac transplant rejection, or distinguishing acute cardiac disorders from pulmonary disorders, by measuring BNP signal peptide levels in a sample taken from a subject shortly after onset of, or presentation with the disorder or transplant rejection.

Abstract: The invention provides binding agents and assays for ghrelin signal peptide. The agents and assays are useful in methods for predicting, diagnosing, assessing or monitoring acute cardiac disorders, glucose handling disorders and diabetes in a subject. Also provided are nucleotides, polypeptides, and kits useful in the methods of the invention.

Abstract: The invention provides methods for predicting, diagnosing or monitoring acute cardiac disorders, cardiac transplant rejection, or distinguishing acute cardiac disorders from pulmonary disorders, by measuring BNP signal peptide levels in a sample taken from a subject shortly after onset of, or presentation with the disorder or transplant rejection.

Abstract: The invention provides methods for predicting, diagnosing or monitoring acute cardiac disorders, cardiac transplant rejection, or distinguishing acute cardiac disorders from pulmonary disorders, by measuring BNP signal peptide levels in a sample taken from a subject shortly after onset of, or presentation with the disorder or transplant rejection.

Abstract: The invention provides binding agents and assays for insulin signal peptide. The agents and assays are useful in methods for predicting, diagnosing, assessing or monitoring acute cardiac disorders, glucose handling disorders and diabetes in a subject. Also provided are nucleotides, polypeptides, and kits useful in the methods of the invention.

Abstract: An adjustable mount for mounting a flat panel display screen on a support comprises a first component adapted for securement to the support and forming a rear of the mount, a second component engaged with the first component and forming a front of the mount to which the screen is intended to be secured, in use, and an adjustment device acting between the first and second components to alter the relative positioning therebetween.

Abstract: A means of measuring and monitoring skeletal growth rate using a plasma analyte, amino-terminal C-type natriuretic peptide (NT-CNP). Plasma NT-CNP concentrations reflect the potential for further growth of the immature skeleton. Measurement of plasma NT-CNP in a subject, when related to the mean of an appropriate age and gender matched set of control subjects, provides an index of the severity of a growth disorder not otherwise available and facilitates diagnosis in children with undetected osteo-chondrodysplasias or other intrinsic disorders of the growth plate. The invention also provides a means of detecting and monitoring potentially harmful effects of drugs and other factors on skeletal growth long before they are evident using current methods in clinical practice.

Abstract: The invention provides methods for predicting, diagnosing or monitoring acute cardiac disorders, cardiac transplant rejection, or distinguishing acute cardiac disorders from pulmonary disorders, by measuring ANP signal peptide levels in a sample taken from a subject shortly after onset of, or presentation with the disorder or transplant rejection. Also provided are antibodies useful in the methods of the invention.

Abstract: The invention provides binding agents and assays for ghrelin signal peptide. The agents and assays are useful in methods for predicting, diagnosing, assessing or monitoring acute cardiac disorders, glucose handling disorders and diabetes in a subject. Also provided are nucleotides, polypeptides, and kits useful in the methods of the invention.

Abstract: A tilting mechanism comprises a first component intended to mount a flat panel display and a second component intended to be secured to a support. The first component has first and second pivots and the second component has first and second elongated slots into which the first and second pivots respectively are received so that the first component can be moved relative to the second component to adjust, in use, the tilt of the flat panel display. In use, an upper one of the elongated slots extends at an angle upwardly and forwardly of the second component, while the lower one of the elongated slots extends upright or upwardly and rearwardly of the second component.